Mayo Clinic researchers will present over 30 studies at ASCO 2026, highlighting new advances in imaging AI, data science, and early cancer detection.
Key Details
- 1More than 30 Mayo Clinic studies will be featured at the 2026 ASCO Annual Meeting.
- 2Highlighted topics include precision oncology, early cancer detection, and AI-driven analysis.
- 3A deep learning approach will be presented to quantify tumor microenvironment features in colon cancer trials.
- 4Research includes multicancer early detection testing and biomarker-driven treatments for various cancers.
- 5Specific sessions will address AI-enabled analysis of postoperative ctDNA status and clinical outcomes.
Why It Matters
Presentations on AI-powered tissue analysis and early detection signal accelerating integration of imaging AI into oncology care. Such advances can inform best practices for radiologists and collaborative cancer care teams.
Source
EurekAlert
Related News
•EurekAlert
AI Clinical Reasoning in Diagnostics and Digital Fatigue in Healthcare
Recent JMIR features explore large language models in clinical diagnostics and digital fatigue among healthcare professionals.
•EurekAlert
AI Method Protects Sensitive Data in ECGs While Retaining Clinical Value
Researchers developed an AI model (PP-VAE) that safeguards sensitive personal data in electrocardiograms without sacrificing clinical utility.
•EurekAlert
AI Model Improves Early Detection of Primary Aldosteronism via EHR Data
An AI-driven model using 30 years of EHR data enhances screening for primary aldosteronism, a frequently underdiagnosed hypertension cause.